Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PMV Pharmaceuticals Inc
PMVP | US
1.59
USD0.01
0.63%
PMVP | US
About PMV Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
21/10/2024
Close
1.59
Open
1.58
High
1.62
Low
1.58
PMV Pharmaceuticals Inc. a precision oncology company engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586 a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing Wild-type p53 or other p53 mutations including R273H R273C R175H G245S R248Q and R282W as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals Inc. and changed its name to PMV Pharmaceuticals Inc. in July 2013. PMV Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Cranbury New Jersey.
View LessPMVP | US
Risk
31.3
Sharpe
-0.33
Luna's Score
49/100
Recommendation
Hold
Luna says (PMVP | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
40.3%1 month
31.3%3 months
38.0%6 months
45.5%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.36
Debt to equity
0.06
Debt to assets
0.05
Ent. to EBITDA
1.24
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-74.84M
MarketCap
81.92M
MarketCap(USD)
81.92M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-22.62
Short ratio
5.82
Short perc.
2.38
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.17
Range1M
0.18
Range3M
0.35
Volumes: Market Activity
Rel. volume
0.41
Price X volume
126.57K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 1.24 | - | Expensive |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.36 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 38.05 | - | Lower Risk |
| Debt to Equity | 0.06 | -1.23 | Expensive |
| Debt to Assets | 0.05 | 0.25 | Cheaper |
| Market Cap | 81.92M | - | Emerging |
